Novartis

News

Novartis appoints new ethics chief after Trump lawyer paymen...

Novartis is aiming to draw a line under a scandal involving payments to Donald Trump's former lawyer with a new ethics chief - Siemens' former compliance head Klaus Moosmayer.

News

Breakthrough designation for Roche/Novartis' Xolair in food ...

Xolair, a drug developed 15 years ago by Roche and Novartis, received a breakthrough designation from the US regulator in a new food allergy indication.

News

Concerns over Teva migraine drug because of manufacturing is...

There are concerns that launch of Teva’s migraine drug may be delayed because of issues uncovered by the FDA at a manufacturing plant run by South Korea’s Celltrion.

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

Novartis freezes drug prices in a nod to Trump

Novartis has announced it would not raise drug prices in the US this year, while Merck & Co announced huge cuts in the price of its hepatitis drug following pressure from president Trum

News

Novartis pays up to $1 billion for potential eczema drug

Swiss pharma Novartis is to pay up to $1 billion to Galapagos and MorphoSys for exclusive rights to a skin drug, which will further strengthen Novartis’s leadership position in the immunolo

Novartis appoints new ethics chief after Trump lawyer paymen...

Breakthrough designation for Roche/Novartis' Xolair in food ...

Concerns over Teva migraine drug because of manufacturing is...

Breakthrough migraine prevention treatment approved in Europ...

Novartis freezes drug prices in a nod to Trump

Novartis pays up to $1 billion for potential eczema drug

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

Novartis

Editor's Picks